Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome
Authors:
- Nicholas J.A. WebbNWNicholas J.A. Webb
- Carolyn J. WatsonCWCarolyn J. Watson
- Ian S.D. RobertsIRIan S.D. Roberts
- Martyn J. BottomleyMBMartyn J. Bottomley
- Caroline A. JonesCJCaroline A. Jones
- Malcolm A. LewisMLMalcolm A. Lewis
- Robert J. PostlethwaiteRPRobert J. Postlethwaite
- Paul E.C. BrenchleyPBPaul E.C. Brenchley
- 1 March 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (3) , 1063-1071
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In VitroJournal of Cell Biology, 1998
- Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.Journal of Experimental Medicine, 1994
- Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factorKidney International, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Hypotensive Activity of Fibroblast Growth FactorScience, 1991
- Release of the Vascular Permeability Factor in Minimal Change Nephrotic Syndrome Is Related to CD4+ LymphocytesNephron, 1990
- Loss of Glomerular Polyanion in vitro Induced by Mononuclear Blood Cells from Patients with Minimal-Change Nephrotic SyndromeAmerican Journal of Nephrology, 1986
- Studies of Vascular Permeability Factor derived from T Lymphocytes and Inhibitory Effect of Plasma on Its Production in Minimal Change Nephrotic SyndromeNephron, 1985
- Immunological studies of minimal-change nephropathy.BMJ, 1980